Security key
019770106
Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO)
CUSIP: 019770106
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Total 13F shares
- 196,986,783
- Total 13F value
- $288,577,139
- Share change
- +8,737,126
- Put/Call ratio
- 38%
- SEC-reported price per share
- $1.46
- Number of holders
- 167
- Value change
- +$11,150,657
- Number of buys
- 89
- Number of sells
- 70
- Shares outstanding
- 244,825,714
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
167
Top holders
10
ALLO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Allogene Therapeutics, Inc. SEC filings
Allogene Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 019770106
Recent filing periods:
Ownership snapshot
Top reported holders of ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
TPG GP A, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
3/4/5
Lead comparable stake: 5.3%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock, Inc.
5.3%
FMR LLC
4.9%
PFIZER INC
9%
TPG GP A, LLC
7.6%
Lynx1 Capital Management LP
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$38,473,455
18,062,655 shares
|
— | 31 Dec 2024 |
| FMR LLC |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$50,634,349
23,771,995 shares
|
— | 31 Dec 2024 |
| PFIZER INC |
13F
Company
|
9%
|
$46,928,245
22,032,040 shares
|
— | 31 Dec 2024 |
| TPG GP A, LLC |
3/4/5
13F
10%+ Owner · Company
|
7.6%
from 13F
|
$59,413,042
18,716,306 shares
|
— | 12 Jan 2022 |
| Lynx1 Capital Management LP |
13F
Company
|
4.4%
|
$23,163,160
10,874,723 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$17,041,474
8,000,692 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
167
Shares
196,986,783
Rows available
167
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
170
Q1 2025 holders
167
Holder diff
-3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend